Fish Oil vs. Krill Oil: Omega-3 Benefits, Absorption, and What Research Shows
BioAdaptives Editorial Team
Which omega-3 supplement is worth your money? A closer look at EPA, DHA, absorption, cardiovascular health, cognitive wellness, and the evidence behind both options.
You're standing in front of two omega-3 supplements. One bottle advertises 1,000 milligrams of fish oil. The other contains 500 milligrams of krill oil and promises better absorption thanks to its phospholipid structure.
The krill oil costs more. Does that mean it's better?
Fish oil and krill oil both provide EPA and DHA, two omega-3 fatty acids important for normal cellular function. Fish oil often delivers more EPA and DHA per serving at a lower cost. Krill oil contains omega-3s partly associated with phospholipids, but research has not established that it consistently produces better health outcomes.
The most useful comparison goes beyond the amount of oil in each capsule. What matters is how much EPA and DHA you're getting, how the formulation has been studied, and whether supplementation makes sense for your nutritional needs.
Understanding those differences can help you choose with confidence rather than relying on marketing claims.
Omega-3 Supplements Explained: Understanding EPA, DHA, and ALA
Omega-3 fatty acids are polyunsaturated fats that contribute to normal cellular structure, communication, and function.
They participate in processes involving cell membranes, lipid signaling, and inflammatory regulation.
Three omega-3 fatty acids are especially relevant to human nutrition.
EPA: Supporting Normal Cellular Signaling
Eicosapentaenoic acid (EPA) is a long-chain omega-3 fatty acid found primarily in marine foods and supplements.
EPA can be incorporated into cell membranes and used to produce signaling molecules involved in inflammatory and other physiological responses.
Researchers have also studied EPA extensively in cardiovascular health, particularly its effects on triglycerides and its role in certain prescription omega-3 treatments.
DHA: An Important Structural Fat in the Brain
Docosahexaenoic acid (DHA) is particularly abundant in certain brain and retinal cell membranes.
Its molecular structure helps influence membrane properties and the activity of membrane-associated proteins.
These functions make DHA important for normal neurological and visual development and function.
However, a nutrient's established biological role does not mean that taking more of it automatically improves memory, concentration, or cognitive performance.
Supplementation benefits must be demonstrated separately in human studies.
ALA: The Plant-Based Omega-3
Alpha-linolenic acid (ALA) is an essential omega-3 fatty acid found in foods such as flaxseeds, chia seeds, walnuts, and certain plant oils.
The body can convert some ALA into EPA and DHA, but conversion is limited, particularly for DHA.
This means that consuming ALA-rich foods does not necessarily produce the same EPA and DHA exposure as eating fatty fish or taking marine omega-3 supplements.
ALA is also different from alpha-lipoic acid, a compound associated with cellular metabolism and antioxidant-related research. BioAdaptives examines that distinction in its article on alpha-lipoic acid and cellular health.
Why Omega-3s Matter for Cellular Wellness
Every cell is surrounded by a membrane composed largely of lipids and proteins.
These membranes help regulate communication, nutrient movement, and responses to the surrounding environment.
EPA and DHA can become incorporated into membrane phospholipids, influencing membrane composition and providing material for important signaling pathways.
DHA is especially relevant to neural membranes, while both EPA and DHA participate in processes involved in inflammatory regulation.
These mechanisms are well established.
What remains more complicated is determining when additional omega-3 intake produces measurable benefits.
That depends on factors such as baseline nutritional status, dose, formulation, age, health conditions, and the outcome researchers measure.
For a broader look at dietary patterns and cognitive wellness, explore BioAdaptives' guide to foods that support brain health.
Fish Oil vs. Krill Oil: What Makes Them Different?
Fish oil generally comes from marine fish, while krill oil is extracted from small marine crustaceans, commonly Antarctic krill.
Both provide EPA and DHA. Their principal differences involve chemical structure, fatty-acid concentration, and additional compounds.
Fish Oil vs. Krill Oil Comparison Table
| Feature | Fish Oil | Krill Oil |
|---|---|---|
| Source | Marine fish | Marine crustaceans |
| Main omega-3 fatty acids | EPA and DHA | EPA and DHA |
| Common chemical forms | Triglycerides, re-esterified triglycerides, or ethyl esters | Phospholipid-associated and other lipid forms |
| EPA and DHA concentration | Often higher per serving | Often lower per serving |
| Astaxanthin | Not a defining component | Naturally present in many formulations |
| Absorption | Varies with formulation, meal composition, and dose | Some studies suggest differences, but results vary |
| Cost per amount of EPA+DHA | Often lower | Often higher |
| Demonstrated clinical superiority | No universal advantage | No universal advantage |
These are general differences, not specifications for every product.
A concentrated fish oil can contain substantially more EPA and DHA than an ordinary fish oil. Krill oil formulations also vary in composition.
The Supplement Facts label is therefore more informative than the product category alone.
Triglycerides, Ethyl Esters, and Phospholipids
In natural fish oil, EPA and DHA are commonly carried in triglycerides.
Some concentrated fish oils contain ethyl esters created during processing. Others use re-esterified triglycerides.
Krill oil contains a substantial proportion of its EPA and DHA associated with phospholipids, including phosphatidylcholine.
Phospholipids have regions that interact with water and regions that interact with fats. This structure makes them important components of biological membranes.
Because digestion and absorption are influenced by the chemical form of dietary fats, researchers have investigated whether phospholipid-associated omega-3s behave differently from other forms.
The question is scientifically meaningful.
But a difference in chemical structure does not, by itself, establish better clinical outcomes.
Does Astaxanthin Give Krill Oil an Advantage?
Krill oil naturally contains astaxanthin, a reddish carotenoid with antioxidant-related properties.
Laboratory research has examined astaxanthin's interactions with oxidative processes.
However, antioxidant activity observed under experimental conditions does not prove that the amount present in a krill oil supplement prevents disease, protects memory, or slows aging.
Those claims require relevant human research using characterized formulations and meaningful health outcomes.
Astaxanthin is a genuine compositional difference. It is not proof that krill oil is the healthier choice.
Is Krill Oil Better Absorbed Than Fish Oil?
Some studies have found favorable absorption measurements with krill oil, while others have found comparable EPA and DHA levels when doses are matched. The evidence does not establish that krill oil is consistently better absorbed than every fish oil formulation.
Two human trials help explain why.
Study One: A Short-Term Absorption Difference
A 2015 randomized, single-blind crossover study compared krill oil, krill meal, and fish oil.
Fifteen participants completed all three intervention periods. Each preparation supplied approximately 1,700 milligrams of total omega-3 fatty acids, but their combined EPA and DHA amounts differed:
- Krill oil: approximately 1,400 mg EPA+DHA.
- Krill meal: approximately 1,102 mg EPA+DHA.
- Fish oil: approximately 1,455 mg EPA+DHA.
Researchers measured changes in blood fatty acids over 72 hours.
Krill oil produced a greater increase in EPA and DHA within plasma phospholipids than fish oil on the study's primary measurement. The difference was statistically significant (p=0.003).
This suggests a short-term difference in how the formulations affected that particular blood fraction.
However, the study was small, the EPA+DHA doses were not identical, and participants received single doses rather than long-term supplementation.
It did not measure memory, cardiovascular events, or other clinical health outcomes.
The investigators also observed substantial variation between participants and noted that the results did not establish a general absorption advantage for phospholipids over triglycerides.
Read the full study by Köhler and colleagues.
Study Two: Similar Omega-3 Levels After Four Weeks
Another randomized, double-blind study published in 2015 compared fish oil ethyl esters, fish oil triglycerides, and krill oil in 66 healthy adults.
Participants were assigned to three groups of 22 and received approximately 1.3 grams of combined EPA and DHA daily for 28 days.
At the end of the study, researchers found no statistically significant differences among the formulations in combined plasma EPA and DHA (p=0.052) or red blood cell EPA and DHA (p=0.19).
The results suggest that these formulations achieved broadly comparable omega-3 exposure under the study conditions.
Importantly, the absence of a statistically significant difference does not prove that every formulation is identical or interchangeable. The trial was limited to the products, doses, participants, and four-week duration studied.
It also did not measure clinical benefits such as fewer heart attacks or improved memory.
Read the study by Yurko-Mauro and colleagues.
Why the Studies Don't Necessarily Contradict Each Other
The two studies measured different aspects of omega-3 exposure.
A single-dose study tracking blood changes over several hours addresses a different question from a four-week study examining circulating and red blood cell fatty acids.
Omega-3 research commonly distinguishes among three types of evidence:
- Short-term absorption: How blood fatty-acid measurements change after consuming a supplement.
- Longer-term omega-3 status: How EPA and DHA become incorporated into blood-cell membranes over time.
- Clinical outcomes: Whether supplementation changes symptoms, functional abilities, or major health events.
One longer-term biomarker is the omega-3 index, which expresses EPA and DHA as a percentage of total fatty acids in red blood cell membranes.
An increase in the omega-3 index demonstrates a change in omega-3 status.
It does not independently prove improved cognition, fewer cardiovascular events, or longer life.
For consumers, the important question is not simply whether one supplement is better absorbed. It's better absorbed according to which measurement, compared with which formulation, and at what dose?
What Does Human Research Say About Omega-3 Benefits?
Omega-3 research covers cardiovascular health, brain function, inflammatory conditions, and healthy aging.
The strength of the evidence differs considerably across these areas.
It is also important to distinguish research on omega-3 fatty acids generally from studies comparing fish oil and krill oil directly.
Cardiovascular Health: Lower Triglycerides Don't Automatically Mean Fewer Heart Attacks
EPA and DHA can reduce elevated triglyceride concentrations at sufficiently high doses.
Triglycerides are fats transported through the bloodstream. Elevated levels can be associated with metabolic disturbances and cardiovascular risk.
But lowering triglycerides is not the same as demonstrating fewer heart attacks or strokes.
The distinction becomes clear when examining two major cardiovascular trials.
The REDUCE-IT trial
Published in the New England Journal of Medicine in 2019, REDUCE-IT studied prescription icosapent ethyl, a purified EPA-derived medication.
The trial enrolled 8,179 statin-treated patients with elevated triglycerides and established cardiovascular disease or diabetes with additional risk factors.
Participants received 4 grams of icosapent ethyl daily or a mineral-oil placebo.
Over a median follow-up of 4.9 years, the primary composite cardiovascular endpoint occurred in:
- 17.2% of participants receiving icosapent ethyl.
- 22.0% of participants receiving placebo.
That represented a 25% relative reduction in the primary composite endpoint (hazard ratio 0.75; 95% confidence interval 0.68–0.83) and a 4.8-percentage-point absolute difference.
The endpoint combined cardiovascular death, nonfatal heart attack, nonfatal stroke, coronary revascularization, and unstable angina.
The trial also reported more hospitalizations for atrial fibrillation or flutter in the treatment group: 3.1% versus 2.1%.
The STRENGTH trial
Published in JAMA in 2020, STRENGTH evaluated a different prescription omega-3 formulation containing EPA and DHA in a carboxylic-acid form.
The trial randomized 13,078 statin-treated patients at high cardiovascular risk to receive 4 grams daily of the omega-3 formulation or corn oil.
Unlike REDUCE-IT, STRENGTH did not demonstrate a reduction in major cardiovascular events.
The primary composite endpoint occurred in 12.0% of the omega-3 group and 12.2% of the control group (hazard ratio 0.99; 95% confidence interval 0.90–1.09).
The trial was stopped early after an interim analysis indicated a low probability of benefit.
The trials differed in formulation, control oil, study population, and other characteristics. Their contrasting results cannot be reduced to a simple claim that EPA works while DHA does not.
More importantly, neither trial establishes that ordinary over-the-counter fish oil or krill oil produces the cardiovascular benefits observed with prescription icosapent ethyl.
Brain Health: Can Omega-3 Supplements Improve Memory?
DHA is an important structural component of neural membranes.
EPA and DHA also participate in biological processes relevant to normal brain function.
These properties make omega-3 fatty acids important subjects for cognitive research.
Some observational studies have associated fish consumption or higher omega-3 exposure with favorable cognitive outcomes.
But people who regularly eat fish may also differ in overall diet, physical activity, or other characteristics.
Observational associations cannot establish that omega-3s caused those differences.
Randomized supplementation trials have produced mixed findings, with results influenced by factors such as age, baseline nutritional status, dose, duration, and the cognitive measures used.
Current evidence does not establish that routine fish oil or krill oil supplementation reliably prevents Alzheimer's disease or improves memory in otherwise healthy adults.
Nor is there convincing direct clinical evidence that krill oil produces superior cognitive outcomes because of its phospholipid composition.
For readers exploring cognitive nutrition more broadly, BioAdaptives examines vitamins and nutrients involved in brain health.
Inflammation, Recovery, and Biological Resilience
EPA and DHA participate in pathways that produce lipid mediators involved in inflammatory responses and their resolution.
These mechanisms are well established in lipid biology.
However, inflammation is not inherently harmful. Normal inflammatory responses help defend the body and support tissue repair.
Clinical studies have investigated omega-3 supplementation in inflammatory conditions, including rheumatoid arthritis. Some findings suggest benefits for selected symptoms or treatment-related measures.
Those findings do not establish that omega-3 supplements eliminate inflammation, accelerate recovery for everyone, or improve physical resilience in otherwise healthy adults.
A change in an inflammatory biomarker also should not be confused with a demonstrated improvement in daily functioning.
Healthy Aging: Promising Biology, Uncertain Supplement Outcomes
Omega-3 fatty acids contribute to biological processes relevant to cardiovascular, neurological, and cellular function.
That makes them relevant to research on healthy aging.
But studies showing changes in blood lipids, omega-3 status, or inflammatory markers do not establish that supplementation slows biological aging or extends lifespan.
A healthy-aging strategy involves more than any single nutrient.
Dietary quality, regular physical activity, restorative sleep, and management of relevant health conditions remain important considerations.
Omega-3 supplementation may have a place in an individual's nutritional approach, but it is not an established longevity intervention.
Evidence Summary: What Is Established and What Remains Uncertain?
| Research question | What the evidence supports | What remains uncertain |
|---|---|---|
| Do fish oil and krill oil provide EPA and DHA? | Yes, although amounts vary by formulation | Whether an individual needs supplementation |
| Is krill oil better absorbed? | Some studies show advantages on selected measurements; others show similar exposure | Consistent superiority across products and populations |
| Can omega-3s lower triglycerides? | Certain preparations at appropriate doses can lower elevated triglycerides | The effect of a specific consumer supplement |
| Do omega-3s prevent cardiovascular events? | A particular prescription EPA treatment has shown benefits in selected high-risk patients | Whether those findings apply to ordinary fish oil or krill oil |
| Do omega-3 supplements improve cognition? | DHA is important in brain biology; supplementation findings are mixed | Reliable memory improvement or dementia prevention |
| Does krill oil's astaxanthin improve health outcomes? | It is a genuine compositional feature with antioxidant-related properties | Clinically meaningful benefits from amounts in finished krill oil products |
| Do omega-3 supplements extend lifespan? | Omega-3 biology is relevant to aging-related systems | Demonstrated lifespan extension |
The central lesson is that evidence belongs to a specific intervention, dose, population, and outcome—not simply to the category "omega-3."
How to Choose Between Fish Oil and Krill Oil
For most consumers, the decision becomes easier when comparing actual nutritional content, cost, quality, and individual needs.
Step 1: Compare EPA and DHA, Not Just Total Oil
Consider these hypothetical Supplement Facts labels:
| Label Information | Fish Oil | Krill Oil |
|---|---|---|
| Total oil per serving | 1,000 mg | 500 mg |
| EPA | 360 mg | 120 mg |
| DHA | 240 mg | 60 mg |
| Combined EPA + DHA | 600 mg | 180 mg |
These values are illustrative, not specifications for particular commercial products.
In this example, the fish oil supplies more than three times as much combined EPA and DHA per serving.
That doesn't make it the right choice for everyone. It does show why the front of the bottle can be misleading.
A supplement containing 1,000 milligrams of oil does not necessarily contain 1,000 milligrams of EPA and DHA.
Step 2: Calculate the Cost per Amount of EPA and DHA
Suppose both hypothetical bottles contain 30 servings.
The fish oil costs $20, while the krill oil costs $30.
The fish oil bottle provides 18,000 milligrams of combined EPA and DHA.
The krill oil bottle provides 5,400 milligrams.
That works out to approximately:
| Cost Comparison | Fish Oil | Krill Oil |
|---|---|---|
| Bottle price | $20 | $30 |
| Total EPA+DHA per bottle | 18,000 mg | 5,400 mg |
| Cost per 1,000 mg EPA+DHA | $1.11 | $5.56 |
In this example, the krill oil costs about five times as much for an equivalent amount of EPA and DHA.
These are hypothetical prices, not current market averages.
The calculation is straightforward:
Bottle price ÷ total EPA+DHA in the bottle × 1,000
This provides a more meaningful comparison than price per capsule alone.
Step 3: Look for Credible Quality Testing
Marine oils can be affected by oxidation, processing, storage conditions, and potential contaminants.
Independent testing can help verify characteristics such as EPA/DHA content, oxidation measurements, and contaminant levels.
Look for credible third-party testing and determine what was actually evaluated.
Not every certification covers the same quality characteristics.
A manufacturer's claim of purity or premium quality is not equivalent to comprehensive independent verification.
Step 4: Consider Tolerability and Safety
Fish oil and krill oil can both cause digestive discomfort, belching, or an unpleasant aftertaste.
People with fish or shellfish allergies should examine ingredient sources carefully. Krill is a crustacean and is particularly relevant to shellfish allergy considerations.
High-dose omega-3 regimens have also been associated with increased atrial fibrillation risk in some cardiovascular trials.
People managing heart-rhythm conditions, taking medications that affect clotting, or considering high-dose supplementation should discuss their circumstances with a healthcare professional.
Prescription omega-3 doses used to treat medical conditions should not be interpreted as general consumer recommendations.
Step 5: Consider Food and Algae-Based Alternatives
Not everyone needs an omega-3 supplement.
Fatty fish such as salmon, sardines, herring, and mackerel naturally provide EPA and DHA alongside protein and other nutrients.
For people who eat fish regularly, additional supplementation may offer limited nutritional value.
Algae-derived omega-3 supplements are another option, particularly for people avoiding fish and shellfish.
Many algae products supply DHA, while some formulations contain both EPA and DHA.
The American Heart Association's guidance on fish and omega-3 fatty acids recommends two servings of fish, particularly fatty fish, per week as part of a heart-healthy dietary pattern.
For detailed information about omega-3 intake, supplement formulations, and safety, consult the NIH Omega-3 Fatty Acids Health Professional Fact Sheet.
Is Fish Oil or Krill Oil More Sustainable?
Neither source is automatically more sustainable.
Fish oil sourcing depends on the fishery, species, harvesting practices, and processing.
Krill harvesting raises different ecological questions because krill plays an important role in Antarctic marine food webs.
Consumers concerned about environmental impact should look for credible, product-specific sourcing information and independent fishery or supply-chain certification.
Sustainability deserves consideration, but it should be evaluated separately from nutritional content and health claims.
Common Misconceptions About Fish Oil and Krill Oil
"Krill Oil Is Better Because It Contains Phospholipids"
Phospholipids are biologically important, and some studies have identified differences in omega-3 exposure.
But an advantage on one absorption measurement does not establish better cardiovascular or cognitive outcomes.
"A 1,000 mg Fish Oil Capsule Contains 1,000 mg of Omega-3s"
Not necessarily.
The stated amount may refer to total oil, which includes fatty acids other than EPA and DHA.
Always check the actual EPA and DHA content.
"More Omega-3 Always Means Better Results"
Higher intake is not automatically more beneficial.
Effects and risks vary with dose, formulation, nutritional status, and individual circumstances.
"Fish Oil Prevents Dementia"
DHA's importance in brain structure does not establish that routine supplementation prevents dementia.
Clinical evidence remains insufficient to support that conclusion.
"Natural Antioxidants Make Krill Oil Superior"
Astaxanthin is a genuine component of many krill oil formulations.
Its presence does not demonstrate that a finished krill oil supplement improves health outcomes more than fish oil.
Omega-3 Nutrition and the Human Renewal Framework
Omega-3 research illustrates a broader principle of lifelong wellness: biological systems work together, and no single nutrient determines how well the body functions.
EPA and DHA participate in cellular membrane structure and signaling. DHA is particularly important in neural tissue, while omega-3 research also examines cardiovascular and inflammatory processes.
These connections fit naturally within BioAdaptives' Human Renewal Framework, which brings together five dimensions:
- Cellular Wellness: Understanding the biological foundations of normal cell function.
- Human Performance: Supporting everyday physical and cognitive capabilities.
- Biological Resilience: Considering the processes involved in adaptation and recovery.
- Healthy Longevity: Maintaining function and well-being throughout life.
- Science-Driven Health Optimization: Making informed choices based on credible evidence.
Omega-3 nutrition connects most directly with Cellular Wellness through membrane biology and with Science-Driven Health Optimization through evidence-based nutritional decisions.
Its relationship to neural function also makes it relevant to cognitive wellness.
BioAdaptives' MyndSystem™ platform is part of the company's broader human-performance and cognitive-wellness strategy. Its documented day-and-night components are MyndMed™ and MyndRenew™.
The company's current ClearMynd website presents MyndMed as a daytime cognitive-support product. ClearMynd identifies itself as a division of BioAdaptives, Inc.
This connection is educational. The available corporate references do not establish that MyndSystem, MyndMed, or MyndRenew contains fish oil, krill oil, or specific omega-3 ingredients. Nor does omega-3 research establish clinical outcomes for these finished products.
The larger lesson is that understanding a biological mechanism is only the beginning. Meaningful wellness decisions require appropriate evidence, realistic expectations, and attention to the whole person.
Frequently Asked Questions
Is fish oil or krill oil better for brain health?
Neither has been established as consistently superior for cognitive outcomes. Both can supply DHA, which is important for normal brain structure. Compare DHA content, quality, and evidence rather than assuming krill oil's phospholipid structure guarantees better brain benefits.
Is krill oil worth the higher price?
It depends on the formulation and your priorities. If your primary goal is obtaining EPA and DHA economically, fish oil often offers better value. Krill oil may still appeal to consumers who prefer its composition, but a higher price does not establish better health outcomes.
Can you take fish oil and krill oil together?
Both contribute EPA and DHA to total intake. There is no established general advantage to taking both instead of choosing an appropriate single source. Consider the combined amount and any relevant medical circumstances.
How much EPA and DHA should adults take?
There is no single supplemental EPA+DHA dose appropriate for every healthy adult. Needs vary according to diet, life stage, and clinical circumstances. Prescription doses used in cardiovascular studies should not be adopted as routine supplement doses.
Is algae oil a good alternative?
Yes. Algae-derived supplements can provide DHA and, depending on the formulation, EPA. They are particularly useful for people avoiding marine animal products. As with fish and krill oil, compare actual fatty-acid content and quality testing.
The Bottom Line: Which Omega-3 Supplement Is Better?
Fish oil and krill oil both provide EPA and DHA, but their concentrations, chemical forms, and costs differ.
Krill oil's phospholipid composition makes it scientifically interesting. Some studies have found favorable short-term absorption measurements, while others have found comparable omega-3 exposure when EPA and DHA doses are matched.
Current evidence does not establish that krill oil consistently produces better cardiovascular, cognitive, or healthy-aging outcomes.
For many consumers, fish oil offers a more economical way to obtain EPA and DHA. Krill oil remains an alternative when its formulation, quality, and cost fit individual preferences.
The most useful decision comes down to four considerations: actual EPA and DHA content, credible quality verification, relevant human evidence, and personal nutritional needs.
Those factors matter more than declaring one oil the universal winner.
Explore Your Human Renewal Profile
Nutrition is one part of lifelong wellness.
BioAdaptives' Human Renewal Profile offers a guided educational experience for exploring how cellular wellness, cognitive performance, resilience, and healthy longevity fit into a broader approach to well-being.
Explore Your Human Renewal Profile
The Human Renewal Profile is an educational wellness experience, not a medical diagnostic tool or an individualized omega-3 dosing assessment.
Scientific References
National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Health Professional Fact Sheet. NIH Omega-3 Fact Sheet. Information on omega-3 biology, intake, formulations, clinical research, and safety.
American Heart Association. Fish and Omega-3 Fatty Acids. AHA dietary guidance.
Köhler A, Sarkkinen E, Tapola N, Niskanen T, Bruheim I. (2015). Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects—a randomized, single-dose, cross-over trial. Lipids in Health and Disease, 14, 19. Full text. DOI: 10.1186/s12944-015-0015-4.
Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N Jr. (2015). Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids in Health and Disease, 14, 99. PubMed. DOI: 10.1186/s12944-015-0109-z.
Bhatt DL, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22. PubMed. DOI: 10.1056/NEJMoa1812792.
Nicholls SJ, et al. (2020). Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA, 324(22), 2268–2280. PubMed. DOI: 10.1001/jama.2020.22258.
Educational information only. Research on individual nutrients, biomarkers, prescription medicines, or platform-level mechanisms should not be interpreted as proof of clinical effectiveness for untested consumer supplements or BioAdaptives finished products.